| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 34,967 | 36,627 | 33,394 | 42,578 | | Cost of Revenue | 11,027 | 12,492 | 10,744 | 13,748 | | | Gross Profit | 23,940 | 24,135 | 22,650 | 28,830 | | | Operating Expenses | | Research Development | 12,764 | 13,343 | 13,566 | 16,135 | | Selling General and Administrative | 10,397 | 11,373 | 11,097 | 12,693 | | Non Recurring | 994 |
-
| 208 | 95,282 | | Others | 1,448 | 1,447 | 1,445 | 1,471 | | | | Total Operating Expenses | 25,603 |
-
| 26,316 | 125,581 | | | | Operating Income or Loss | (1,663) | (2,028) | (3,666) | (96,751) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (5,508) | | Earnings Before Interest And Taxes | (1,744) | (2,028) | (3,666) | (97,320) | | Interest Expense | (602) | (445) | 1,047 |
-
| | Income Before Tax | (1,142) | (1,583) | (4,713) | (97,320) | | Income Tax Expense | (2,632) | (345) | (1,606) | 234 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,490 | (1,238) | (3,107) | (97,554) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,490 | (1,238) | (3,107) | (97,554) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,490 | ($1,238) | ($3,107) | ($97,554) |
|
0.11% Nasdaq 
0.01%
Income Statement
